Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.

about

Pediatric Statin Administration: Navigating a Frontier with Limited Data Current and Emerging Uses of Statins in Clinical Therapeutics: A Review Pharmacogenetics in clinical pediatrics: challenges and strategies.

P2860

Q28068014-2535C7C2-5927-4523-8060-A321EFD880E3 Q28076346-5F3AD2F4-7B24-49E7-8931-C9475E83CB0E Q37400384-90A3523A-2C07-4D7A-B053-9D51FDCF49BE

P2860

Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.

Item

http://www.wikidata.org/entity/Q38049379

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pediatric pharmacogenomics: a ...... of statin studies in children.

@en

type

Item

label

Pediatric pharmacogenomics: a ...... of statin studies in children.

@en

prefLabel

Pediatric pharmacogenomics: a ...... of statin studies in children.

@en

P1476

Pediatric pharmacogenomics: a ...... of statin studies in children.

@en

P2093

J Steven Leeder

http://www.w3.org/2001/XMLSchema#string

Jonathan Wagner

http://www.w3.org/2001/XMLSchema#string

P2860

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters

Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

Genetic contribution to variable human CYP3A-mediated metabolism

Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

P304

1017-1037

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PCL.2012.07.008

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23036242

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

5847265

http://www.w3.org/2001/XMLSchema#string

Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.

about

P2860

P2860

Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932